Trex Medical
This article was originally published in The Gray Sheet
Executive Summary
Full-field digital mammography system is found "not substantially equivalent" to film screen mammography systems, the company announces Aug. 6. The Thermo Electron subsidiary submitted additional data to FDA earlier this year after announcing that its 510(k) application had been withdrawn last December. The agency has indicated "several alternatives" to facilitate approval of the product and plans to discuss "the best possible use of the data" already collected in a meeting with Trex later this month. "We anticipate that design changes and additional clinical data are likely to be required," CEO Bill Webb notes
You may also be interested in...
Thermo Electron Places Trex, Thermo Cardiosystems On Auction Block
Trex Medical's premarket approval application submission for its full-field digital mammography system is likely to coincide with the divestment of the company by parent Thermo Electron.
Thermo Electron Places Trex, Thermo Cardiosystems On Auction Block
Trex Medical's premarket approval application submission for its full-field digital mammography system is likely to coincide with the divestment of the company by parent Thermo Electron.
PMA May Be Least Burdensome Path For Digital Mammography - Feigal
Trex Medical expects to meet with FDA within the next two weeks to determine the next step in its long-sought pursuit of commercial go-ahead for its full-field digital mammography system, the company says.